$DSY

Key facts: Dassault Systemes SE Q3 €1.55B; ArisGlobal; Medidata leader

Dassault Systemes (DSY) reported Q3 revenue of €1.55B, up 5% YoY, with operating profit of €490M and margin of 31.6%. The company raised its 2026 revenue growth target to 4-5% and margin target to 32.5-32.7%. DSY also completed the acquisition of ArisGlobal, expecting strong multi-year growth, and Medidata was named a leader in IDC MarketScape 2026 for its AI-driven platform.

Original reporting
Published Oct 28, 2026, 8:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: Dassault Systemes SE Q3 €1.55B; ArisGlobal; Medidata leader — source image
Decision brief

The 30-second read

$DSYBullishMed
01

Why it matters

The earnings beat and acquisition are likely to drive short‑term buying interest, while longer‑term growth depends on integration success.

02

Market read

First‑report earnings and M&A news for a major European tech firm, providing fresh data for traders.

03

What to watch

Currency fluctuations (EUR/USD) and potential regulatory scrutiny of the acquisition in the EU.

Relevance 7/10Novelty 7/10Timing: immediate today

Background

The article is a brief AI‑generated summary of Dassault Systèmes' Q3 results and its recent acquisition.

Company-level read

Ticker impact

$DSYBullishHigh confidence
Context

Dassault Systèmes reported Q3 revenue of €1.55B (+5% YoY) and closed its acquisition of ArisGlobal, raising its 2026 guidance.

Expected impact

likely upward pressure as market prices in higher revenue and growth guidance.

Evidence & confidence

Both the earnings numbers and the completed acquisition are fresh primary disclosures that improve growth outlook.

Market effects

Strengthens the life‑sciences software segment and may lift peers in the PLM/clinical‑trial software space.

European tech earnings boost sentiment for French and broader EU tech stocks.

Adds to the narrative of AI‑driven health‑tech growth worldwide.

Counterpoint

If integration costs of ArisGlobal exceed expectations, the guidance uplift could be overstated.

Key entities

  • Dassault Systèmes SE

    French software giant listed on NYSE as DSY.

  • ArisGlobal

    Life‑sciences software maker acquired by Dassault Systèmes.

Related articles

$DSYHighAI 8/10

Cloud software sales rose 14%, and recurring revenue made up 84% of software sales.

Dassault Systèmes (DSY.PA) reported Q3 2026 revenue growth of 5% to €1.55B, with software revenue up 5% and cloud software sales rising 14%. Recurring revenue made up 84% of software sales. Operating margin improved to 31.6%, and diluted EPS increased 8% to €0.32. The company raised its full-year revenue and margin targets, citing strong performance and the ArisGlobal acquisition.

$DSYHighAI 9/10

Dassault Systèmes to acquire ArisGlobal, creating a unified AI intelligence platform for the Life Sciences industry connecting molecule, patient and real

Dassault Systèmes (Euronext Paris: DSY.PA) said it signed a definitive agreement to acquire ArisGlobal for about $1.8 billion in cash at closing, plus up to $200 million tied to multi-year AI revenue milestones. ArisGlobal is expected to generate $175 million revenue in 2026 and serves 200+ customers. Closing is expected in 2H 2026 subject to approvals.

$DSYHighAI 9/10

Dassault Systèmes to Acquire ArisGlobal, Creating a Unified AI Intelligence Platform for the Life Sciences Industry Connecting Molecule, Patient and Real-World Outcomes

Dassault Systèmes (Euronext Paris: DSY.PA) said it signed a definitive deal to acquire ArisGlobal for about $1.8 billion cash at closing plus up to $200 million tied to multi-year AI revenue milestones. ArisGlobal is expected to generate $175 million revenue in 2026 and serves 200+ customers. Closing is expected in 2H 2026, subject to approvals.